ACT Brief: Site Satisfaction, eSource Data Transfers, and Gilead HIV Trial Results

Nov 14, 03:00 PM

Subscribe
In today’s ACT Brief, we examine declining site satisfaction and strategies to improve sponsor-site collaboration, review a new partnership enabling automated eSource-to-EDC data transfer, and highlight Gilead’s positive Phase III ARTISTRY-1 trial results in virologically suppressed adults with HIV.